Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRISPR-engineered deletion of POGZ alters transcription factor binding at promoters of genes involved in synaptic signaling.

HGG advances·2026
Same author

BMI-genome interactions regulate global gene expression with emphasis in brain and gut.

Cell genomics·2026
Same author

Single-nucleus epigenomic dysregulation unmasks genetic risk-associated neurodegenerative glia states.

Nature communications·2026
Same author

R-loop landscapes in the developing human brain are linked to neural differentiation and cell type-specific transcription.

Translational psychiatry·2026
Same author

Convergent coexpression reveals shared biological mechanisms underlying common and rare variant risk in six neuropsychiatric disorders.

Molecular psychiatry·2026
Same author

MASTR-seq enables multiplexed analysis of short tandem repeats with sequencing.

Cell reports methods·2026

Related Experiment Video

Updated: May 5, 2026

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry
08:52

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry

Published on: April 6, 2022

5.7K

Inducing cellular aging: enabling neurodegeneration-in-a-dish.

Kristen J Brennand1

  • 1Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.

Cell Stem Cell
|December 10, 2013
PubMed
Summary

Human induced pluripotent stem cells (hiPSCs) can now model aging-related diseases. This new strategy helps study late-onset neurodegenerative disorders like Parkinson's disease in vitro.

More Related Videos

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans
07:04

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans

Published on: August 15, 2020

4.9K
Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

34.3K

Related Experiment Videos

Last Updated: May 5, 2026

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry
08:52

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry

Published on: April 6, 2022

5.7K
Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans
07:04

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans

Published on: August 15, 2020

4.9K
Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

34.3K

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Disease Modeling

Background:

  • Human induced pluripotent stem cells (hiPSCs) are valuable for disease modeling.
  • Neurons derived from hiPSCs often exhibit immaturity, hindering the study of late-onset neurodegenerative disorders.
  • Modeling diseases like Parkinson's disease in vitro is challenging due to the lack of aged neuronal phenotypes.

Purpose of the Study:

  • To develop a method for inducing aging-related phenotypes in hiPSC-derived neurons.
  • To enable in vitro modeling of late-onset neurodegenerative diseases using hiPSC technology.

Main Methods:

  • Utilizing a specific strategy to promote neuronal maturation and aging in hiPSC-derived neurons.
  • Characterizing the induced aging-related phenotypes in vitro.

Main Results:

  • Successfully induced aging-related phenotypes in hiPSC-derived neurons.
  • Established a viable in vitro model for studying late-onset neurodegenerative conditions.

Conclusions:

  • The developed strategy overcomes the immaturity barrier of hiPSC-derived neurons.
  • This approach facilitates the in vitro investigation of late-onset neurodegenerative diseases, including Parkinson's disease.